Fig. 7
From: Identification of a Notch transcriptomic signature for breast cancer
Analysis of the 20-gene signature score in the BEAUTY breast cancer cohort. A The 20-gene signature score analysed as gene set variation analysis (GSVA) in TNBC, HER2, Luminal A (LumA) and Luminal B (LumB) patients for the non-responder group before treatment from the BEAUTY cohort. B Analysis of the signature score before or after neoadjuvant chemotherapy (paclitaxel and anthracycline) for the non-responder patient group in A, as indicated in the figure. C The baseline pre-treatment GSVA score for TNBC responders and non-responders as indicated. (*p < 0.05)